Speaker Profile
Ph.D., Co-Founder & CSO, BioSymetrics
Biography
Dr. Musso has a background in molecular genetics (PhD), and did post-doctoral work at Harvard Medical School and Brigham and Women's Hospital on computational and developmental biology. He spent time at a start-up working on real-time machine learning, before joining with others to start BioSymetrics with the aim of tackling the specific challenges of working with biomedical data. He was named one of the top 100 leaders in AI and drug discovery, has authored over 30 peer reviewed publications on AIML and biology.
Talk
Building Advanced Patient Diagnostic Frameworks using AI
The recent evolution of AI models has presented renewed optimism for precision medicine and disease diagnosis, but how much will truly be clinically impactful? This talk explores the development of AI-driven frameworks that integrate diverse data types, improving detection of patient sub-groups and enabling development of precision medicines in neurological disease.
Clinical Dx Showcase:
BioSymetrics
BioSymetrics uses a proprietary AI platform to analyze clinical data, scale in vivo screening, and expedite identification and development of novel therapeutics.
Session Abstract – PMWC 2025 Silicon Valley
The PMWC 2025 Data Applications in Clinical Diagnostics Showcase will provide a 15-30 minute time slot for selected organizations, including commercial companies, clinical testing labs, and medical research institutions, to present their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients. We will learn about new technologies and findings that promise expedited, cost-effective, and accurate clinical diagnosis for early disease detection, treatment decisions, and disease prevention.
- Clinical Dx/Oncology (including Liquid Biopsy)
- Clinical Dx/Cardio Vascular
- Clinical Dx/Neurodegenerative
